Tag Archives: Years

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older Print this page WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today that the U.S. Food and Drug Administration (FDA) has approved Katerzia (amlodipine)… Read More »

Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?

Merck hasn’t exactly made a fortune on its $ 9.5 billion Cubist Pharmaceuticals buyout, but now, a next-gen antibiotic it acquired in that deal has a brand-new indication that could help jump-start sales. On Monday, the FDA approved that drug, Zerbaxa, to treat adults with hospital-acquired and ventilator-associated pneumonia. It’s an add-on to Zerbaxa’s original approvals—to treat complicated… Read More »